1/117
Looks like no tags are added yet.
Polymyalgia rheumatica pathophys
IL-6 mediated inflammation of synovium and periarticular tissue
Polymyalgia rheumatica clinical presentation
Age over 50 years
Markedly elevated ESR and CRP
Pain and stiffness in shoulders and hips lasting for several weeks without other explanation
Polymyalgia rheumatica commonly occurs with
giant cell arteritis but not always
Polymyalgia rheumatica history
Profound stiffness and pain in shoulders, hip, low back
Fatigue
-trouble combing their hair, putting on a coat, or rising from a chair
Polymyalgia rheumatica is NOT
Muscle weakness (inflammation or nerve infarction)
Polymyalgia rheumatica PE
No muscle weakness
Decreased active ROM in shoulders/hips
Low grade fever
Weight loss
Polymyalgia rheumatica initial diagnostics
ESR >30
CRP >0.5
Negative autoantibodies
US/MRI shows bursitis tenosynovitis
Polymalgia rheumatica differential dx
RA
Late-onset spondyloarthritis
Myopathies
Hypothyroidism
Malignancy or infx
Polymyalgia rheumatica management
Low dose prednisone
anti-IL-6Ra antibody, Sarilumab for refractory
Polymyalgia rheumatica drug classifications of all medications
corticosteroids
Sarilumab is a biologic DMARD, monoclonal antibody (anti-IL-6Ra antibody)
Prednisolone management of polymyalgia rheumatica
Low dose
10-20mg/day orally
Should see dramatic improvement within 72 hours
May be able to taper after 2-4 weeks but will require small dose for a year
Prednisolone management of giant cell arteritis
High dose
40-60mg/day orally
1mg/kg/daily or max 80mg/day
Continue 1 month then taper
Giant cell arteritis tx
High dose prednisone
AND
IL-6 receptor Tocilizumab subcu weekly
AND
Low-dose ASA for ischemia prevention
-For all pts with new or relapsing GCA
Giant cell arteritis
Inflammation of medium and large arteries
-granulomatous vasculitis
-giant cells disrupt elastic lamina
-leads to vessel wall thickening and ischemia
Giant cell arteritis clinical presentation
Age over 50 years
Markedly elevated ESR and CRP
HA
Jaw claudication
Visual sx
Systemic sx (fever, fatigue, wt loss)
Limb claudication, possible aneurysm
Polymyalgia rheumatica in 40-60%
When giant cell arteritis is suspected
immediately initiate oral prednisone and STAT temporal artery biopsy or temporal artery ultrasound
GCA PE
Tender/thickened temporal artery
Possible bruits, reduced pulses
When pt with giant cell arteritis seeks help for vision loss
IV pulse methylprednisolone (1g daily for 3 days) should be started but will likely not be successful
Also STAT temporal artery bx
Giant cell arteritis gold standard for diagnosis
is temporal artery biopsy
Giant cell arteritis classic sx
HA
Scalp tenderness
Visual sx
Jaw claudication (highest positive predictive value)
Without treatment for giant cell arteritis
blindness may occur
Giant cell arteritis can involve
all medium-sized and large vessels
Giant cell arteritis requires all of the following
Clinical
Laboratory
Pathologic (temporal artery bx)
Imaging
Giant cell arteritis imaging
Temporal artery ultrasound
AND
Large-vessel imaging
CT
MRI
or
PET
Giant cell arteritis initial diagnostics
ESR >50 (often >100)
mild anemia
thrombocytosis (high PLT) possible
elevated alkaline phosphatase
GCA differentials
Takayasu arteritis
Non-arteritic anterior ischemic optic neuropathy
Infx of neoplasms
Other visual or HA disorders
Raynaud phenomenon diagnosis
Well-demarcated bilateral digital pallor and/or cyanosis followed by rubor
Precipitated by cold or emotional stress, relieved by warmth
Affects young women
Primary vs secondary
Raynaud phenomenon treatment
Keep the body warm
Protect hands from injury
Use lotion frequently
Stop smoking
Avoid decongestants and amphetamines
Raynaud phenomenon pharm tx
CCBs (nifedipine, amlodipine) for primary
ARBs, topical nitrates, PDE inhibitors (sildenafil, etc), or fluoxetine for secondary
Rheumatoid arthritis
Insidious onset
Morning stiffness and joint pain
Symmetric polyarthritis
Affects small joints of hands and feet
Deformities common with progressive disease
X-ray - joint erosions, joint space narrowing, bone loss near joints
Subcutaneous nodules
Dry eyes, mouth, mucus tissue
Interstitial lung dz
Pleural effusion
Pericarditis
Splenomegaly
Scleritis
Vasculitis
Rheumatoid arthritis labs
RF and anti-CCP present 70-80% of the time
RA vs OA
Symmetric swelling of multiple joints with tenderness and pain
Stiffness persists longer than 30 minutes, common in the morning, more severe after activity
-PIP joints, MCP joints, wrists, knees, ankles, and MTP
-OA spares the MCPs and wrists
RA tx
DMARDs should be started as soon as the diagnosis is made, adjusted to suppress dz activity
Low-dose corticosteroids (prednisone 5-10mg PO daily) to bridge in pts needing prompt relief, not more than 3 months (doses higher than 10mg daily not appropriate)
NSAIDs for symptomatic relief (only in conjunction, if at all)
-use standardized assessments like Disease Activity Score 28 Joints or Clinical Disease Activity Index
DMARDs
Methotrexate - first line.
Effects in 2-6 weeks.
Synthetic.
7.5 or 10mg PO weekly initial dose.
Teratogenic
Contraindications: eGFR
Other DMARDs
Sulfasalazine - used in combination with methotrexate, monitor CVC Q2-4 weeks for 3 months, then Q3 mos. Check G6PD deficiency before starting.
Leflunomide (pyrimidine synthesis inhibitor) - alternative for those who cannot take methotrexate. Teratogenic.
Antimalarials
Janus kinase inhibitors (Tofacitinib) for severe RA refractory to methotrexate or other agents. Screen for TB. Increases risk of infx.
Biologic DMARDs
TNF inhibitors (added to methotrexate). Screen for TB before starting.
Abatacept blocks T-cell stimulation.
Rituximab - depletes B cells.
RA stepwise tx
1-methotrexate
2-methotrexate + sulfasalazine + hydroxychloroquine
3-methotrexate + DMARD
SLE
occurs mainly in young women
-rash in areas exposed to sun
-joint sx in 90%
-anemia, leukopenia, thombocytopenia
-glomerulonephritis, CNS dz, complications of antiphospholipid syndrome = morbidity
SLE lab results
ANA antibodies (100%)
anti-dsDNA antibodies (2/3)
low serum complement levels (during flares)
elevated ESR during flares
CRP usually normal
In SLE, hematuria
with or without casts, and proteinuria can indicate active lupus nephritis
SLE gold standard of testing
SLE should never be diagnosed without an elevated ANA titer (80 or higher)
-clinical signs also need to be present
Criteria for diagnosis, points awarded for
fever
leukopenia
thrombocytopenia
autoimmune hemolysis
delirium
psychosis
seizure
non-scarring alopecia
oral ulcers
subacute cutaneous or discoid lupus
acute cutaneous lupus
pleural or pericardial effusion
acute pericarditis
joint involvement
proteinuria >0.5
renal biopsy proven lupus nephritis
anti-cardiolipin antibodies OR anti-beta-2-GP1 antibodies OR lupus antigoaculant
Low C3 or C4 complement
Anti-dsDNA antibody or anti-smith antibody
SLE tx
-sunscreen
-topical corticosteroids for rash
-NSAIDs for joint sx
-hydroxychloroquine for skin/joint
-corticosteroids for certain sx
-immunosuppressive drugs (mycophenolate mofetil, azathioprine, methotrexate).
SLE tx of lupus nephritis
mycophenolate mofetil (1000mg or 1500mg PO BID)
AND
corticosteroids - methylprednisolone 250-1000mg IV over 30 minutes daily x3 days
OR
prednisone 40-60mg PO
SLE lupus nephritis management
mycophenolate mofetil or azathioprine
Prednisone tapered down to 5mg daily then d/c
Large vessel vasculitis clinical presentation
Fever, weight loss, malaise, arthralgias/arthritis
Limb claudication
Asymmetric blood pressures
Absence of pulses
Bruits
Aortic dilation
Medium vessel vasculitis clinical presentation
Fever, weight loss, malaise, arthralgias/arthritis
Cutaneous nodules
Ulcers
Livedo reticularis
Digital gangrene
Mononeuritis multiplex
Microaneurysms
Small vessel vasculitis clinical presentation
Fever, weight loss, malaise, arthralgias/arthritis
Purpura
Vesiculobullous lesions
Urticaria
Glomerulonephritis, hematuria
Alveolar hemorrhage
Cutaneous extravascular necrotizing granulomas
Splinter hemorrhages
Uveitis
Episcleritis
Scleritis
Vasculitis diagnosis
No specific lab values
ANCA may be positive (antineutrophil cytoplasmic antibodies)
Large vessel dz - MRA
Medium vessel dz - biopsy or vascular imaging like angiography (deep biopsy, not punch bx of ulcer)
Vasculitis tx
High dose pulse methylprednisolone (1g IV daily x3 days)
AND
cyclophosphamide
THEN
methotrexate or azathioprine to maintain remission
Scleroderma limited dz
CREST syndrome
skin thickening/hardening confined to face, neck, and digital extremities
Calcinosis
Raynaud phenomenon
Esophageal motility disorder
Sclerodactyly
Telangiectasia
(higher risk for losing fingers d/t ischemia and pulmonary HTN)
Slceroderma diffuse dz
widespread thickening of skin, with areas of increased pigmentation and depigmentation
Diffuse scleroderma clinical presentation
Common early:
polyarthralgia
weight loss
malaise
Other:
skin changes involving trunk, proximal extremities
subcutaneous edema associated with pruritus
Skin becomes thickened and hidebound, loses normal folds
Telangiectasia, pigmentation, depigmentation common
Ulceration of fingertips
Tendon friction rubs over forearms and shins
Restrictive lung dz
Cardiac abnormalities
Renal crisis
Scleroderma systemic features
gastroesophageal reflux, GI hypomotility, pulmonary fibrosis, pulmonary HTN, renal involvement
Scleroderma presentation
-raynaud phenomenon and antinuclear antibodies are present in virtually all patients
Scleroderma labs
Mild anemia (hemolytic)
Normal ESR
Mild proteinuria
ANA positive and high
anti-SCL-70 only 20-30% and poor prognosis
Anticentromere antibodies in 50% with limited dz
Anti-RNA polymerase III antibodies 10-20% assoc w/ rapid dz, renal crisis, higher risk of cancers, esp breast ca
Differentiate scleroderma and sclerederma
Sclerederma assoc w/ diabetes or inection
Skin thickening of the posterior neck, shoulders, upper back
Spares the fingers!
Scleroderma tx
No tx for dz process
Treat organ systems involved
prednisone is NOT used!
Scleroderma tx for skin
methotrexate
OR
mycophenolate mofetil
Scleroderma renal crisis tx
Hospital!
ACEi
Scleroderma GI tx
avoid late night meals and use PPIs
Small, frequent meals
Remain upright
Metoclopramide
Scleroderma lung dz
Mycophenolate mofetil can improve dyspnea and PFTs modestly
Common causes of lymphadenopathy
Benign
Viral (esp. children/young adults)
Mono
CMV
HIV
Medication (phenytoin)
SLE, sarcoidosis (bilateral hilar nodes)
Lymphoma
Acute leukemia
Disseminated TB
Lymphadenopathy, suspect mono if
fever
pharyngitis
posterior cervical nodes
Lymphadenopathy, suspect CMV if
mono-like illness
Lymphadenopathy, suspect HIV if
ulcers
rash
pharyngitis
Lymphadenopathy, suspect lymphoma if
persisten, non-tender, firm, or matted nodes with B symptoms (fever, night sweats, weight loss)
Lymphadenopathy, suspect acute leukemia if
lymphadenopathy
cytopenias
constitutional sx (fever, frequent infx, fatigue, weakness, wt loss, night sweats)
Lymphadenopathy, suspect disseminated TB if
immunocompromised/high risk pts
Lymphadenopathy h&p
Ask about fever, wt loss, night sweats, rash, pharyngitis, arthralgias, duration of LAD, exposure, travel, medication hx
PE: node features, organomegaly
H&P is key for diagnosis
Lymphadenopathy labs
CBC w/ diff
smear
LFTs
HIV
EBV/CMV
ANA
Lymphadenopathy imaging
CXR
PET-CT
CT
US
Excisional bx if malignancy suspected
Unintentional wt loss in older adults, consider
Metabolic causes
Cancer
Medication related changes (taste, nausea, anorexia, etc)
Dental changes
Depression
Social factors (poverty, ADLs)
Unintentional wt loss labs
CBC
BMP
LFTs
Thyroid
CRP
ESR
Glucose
Lactate dehydrogenase
Urinalysis
CXR
Fecal occult
Abdominal US (consider)
Unintentional wt loss, if baseline evaluation is unremarkable
observation for 3-6 months
Unintentional wt loss tx
Treat cause
Nutritional supplements
Flavor enhancers
Dietary modification for chewing or swallowing
Appetite stimulants may increase wt but have serious SE (megestrol, mirtazapine, cyproheptadine)
Unintentional wt loss, definition
More than 5% reduction in body weight within 6-12 months
Causes of unintentional wt loss
Malignancy (but less common than non-malignant)
GI dz (non-malignant)
Psychiatric (depression and dementia)
Unknown causes
Endocrine
Cardiopulmonary
Alcohol-related
Infx
Neurologic
Rheumatic dz
Renal dz
Systemic inflammatory disorders
Meals on Wheels
Medication effects
Emotional problems (depression)
Anorexia nervosa
Late-life paranoia
Swallowing disorders
Oral factors (dentures, caries)
No money
Wandering and dementia
Hyperthyroidism, hypothyroidism, hyperparathyroidism, hypoadrenalism
Enteric problems
Eating problems (inability to feed self)
Low-salt and low-cholesterol diet
Stones, social problems (isolations)
9 Ds of weight loss
Dementia
Dentition
Depression
Diarrhea
Disease (acute and chronic)
Drugs
Dysfunction (functional disability)
Dysgeusia
Dysphagia
Unintentional weight loss h&p
Amount of weight lost
Time frame
Assess appetite
Medications and supplements
Alcohol/tobacco/living situation
ROS to detect acute illness or worsening chronic conditions (esp cardiovascular, resp, GI)
Use tools like nutritional health checklist
Assess psychiatric (PHQ-2, Geriatric depression scale, mini-cog)
Unintentional weight loss symptoms
Fever, fatigue = Infx, autoimmune, malignancy, DM, thyroid
Dysphagia, oral/gum problems = dentures, esophageal stricture
Dyspnea, exertional fatigue = CHF, pulmonary infx, worsening emphysema, COPD
Indigestion, abd pain, change in stool pattern, early satiety = GA malignancies, peptic ulcer dz, dyspepsia, GERD, cholecystitis
Anorexia nervosa diagnosis
Energy restriction
Significantly low body weight
Distorted body image
Intense fear of gaining weight
(Distorted perception of body image, undue influence of weight on self-worth)
Refusal to exceed a minimal healthy weight
(Denial of the medical seriousness of underwt status)
-Must exclude other medical or psychiatric illnesses that can account for anorexia and weight loss
Anorexia nervosa differentials
Bulimia nervosa
Binge-eating disorders
Panhypopituitarism
Addison dz
Hyperthyroidism
DM
GI disorders (Crohn dz, gluten)
Chronic infx (TB)
Cancers (lymphoma)
Rare CNS disorders (hypothalamic tumor)
Anorexia classifications
Mild - BMI 17-18.49
Moderate - BMI 16-16.99
Severe - BMI 15-15.99
Extreme - BMI less than 15
Anorexia nervosa subtypes
Binge-eating/purging (vomiting or diuretics, laxatives, enemas, cathartics)
Restricting (dieting, fasting, excessive exercising)
Anorexia s/s
Severe emaciation
Cold intolerance or constipation
Bradycardia
Hypotension
Hypothermia
Loss of body fat
Dry and scaly skin
Increased lanugo
Parotid enlargement/edema
Cessation of menstruation
Important diseases that cause fatigue
Hyper- and hypothyroidism
Hyperparathyroidism
HF
Infx (endocarditis, hepatitis, mono, sinusitis)
COPD
Asthma
Interstitial lung dz
ESKD
Sleep apnea
Anemia
Autoimmune disorders
MS
IBD
IBS
Parkinson dz
Cerebral vascular accident
Cancer
Alcohol use disorders
Vitamin C deficiency
SE from meds
Psych conditions
Systemic Exertion Intolerance Dz (Chronic fatigue syndrome) diagnosis requires all 3:
1-Substantial reduction or impairment in the ability to engage in pre-illness levels of occupational, educational, social, or personal activities that persists for more than 6 months and is accompanied by fatigue, which is often profound, of new or definite onset (not lifelong), not the results of ongoing excessive exertion, and is not substantially alleviated by rest.
2-Postexertional malaise
3-Unrefreshing sleep
AND must have at least one:
1-cognitive impairment
2-orthostatic intolerance (lighteheadedness, dizziness, HA)
Chronic fatigue workup
CBC
ESR
Kidney function
Serum electrolytes
Glucose
Creatinine
Calcium
Liver tests
Thyroid
UA
TB
Psych screening
Fatigue tx for HF, COPD, arthritis, cancer
resistance training and aerobic exercise
Fatigue tx for OSA
CPAP
Pitolisant (H3-receptor antagonist with wake-promoting effect for those who refuse CPAP
Fatigue tx for cancer
Psychostimulants such as methylphenidate (Ritalin) for cancer-related fatigue
Fatigue tx for TBI
Methylphenidate and CBT
Fatigue tx for HIV
Modafinil and armodafinil
-can also be used as adjunctive for depression and bipolar
Fatigue tx for hypoandrogenic men
Testosterone - improves mood but not function
Fatigue tx for kidney transplant pts
vitamin D
-also for those who are deficient
Fatigue tx for breast cancer pts
CBT
Therapeutic Care (acupressure)
Swedish massage for those who had surgery + radiation, chemo, or both
Fatigue tx for Parkinson dz
rasagiline
modafinil
doxepin
Fatigue tx that does not work
Exceeding RDA for protein
Drugs for MS